Illumina, Grail should win appeals against EU Commission’s jurisdiction over their merger, legal opinion says
MLex Summary: US life-sciences company Illumina and cancer-testing startup Grail should win their legal challenges to the European Commission's jurisdiction to review their merger, according to a non-binding legal opinion for...To view the full article, register now.
Already a subscriber? Click here to view full article